Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD) | BEB-Y10-100ug

Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD) | BEB-Y10-100ug| Gentaur Distribution US, UK & Europe

A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.

Source: Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and BN/Alymphocytes obtained from a mouse immunized with Bevacizumab F (ab') 2.

Molecule: Bevacizumab.

Species: Mouse.

Tag: N/A.

Conjugate: Unconjugated.

Purity: 95%.

Charactirization: Tris with Glycine,  Arginine and NaCl,  pH7.5.

Storage Conditions: -20℃.

Shipping Conditions: RT